File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: The Prognostic Role of Perineural Invasion for Survival in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

TitleThe Prognostic Role of Perineural Invasion for Survival in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
Authors
Keywordshead and neck squamous cell carcinoma
perineural invasion
prognosis
survival
Issue Date1-Jul-2024
PublisherMDPI
Citation
Cancers, 2024, v. 16, n. 14 How to Cite?
AbstractThe aim of this study was to conduct a comprehensive review of the predictive significance of PNI in HNSCC survival outcomes. A systematic search was conducted across multiple databases, and all studies published in the last decade were screened (Research Registry ID: reviewregistry1853). The included studies were assessed using the Quality in Prognosis Studies tool. Survival outcome data were extracted, combined, and presented as hazard ratios (HR) with a 95% confidence interval (CI). Totally, 74 studies encompassing 27,559 patients were analyzed and revealed a cumulative occurrent rate of 30% for PNI in HNSCC. PNI+ HNSCC patients had a worse overall survival (HR: 1.91, 95% CI: 1.71–2.13), disease-specific survival (HR: 1.79, 95% CI: 1.55–2.07), disease-free survival (HR: 1.82, 95% CI: 1.69–1.96), local recurrence (HR: 2.54, 95% CI: 1.93–3.33), locoregional recurrence (HR: 2.27, 95% CI: 1.82–2.82), locoregional relapse free survival (HR: 1.77, 95% CI: 1.28–2.45), distant metastasis (HR: 1.82, 95% CI: 1.34–2.48), and distant metastasis-free survival (HR: 2.97, 95% CI: 1.82–4.85) compared to those PNI– patients. The available evidence unequivocally establishes PNI as a critical prognostic factor for worse survival in HNSCC patients.
Persistent Identifierhttp://hdl.handle.net/10722/369641
ISSN
2023 Impact Factor: 4.5
2023 SCImago Journal Rankings: 1.391

 

DC FieldValueLanguage
dc.contributor.authorTao, Zhuo Ying-
dc.contributor.authorChu, Guang-
dc.contributor.authorSu, Yu Xiong-
dc.date.accessioned2026-01-30T00:35:39Z-
dc.date.available2026-01-30T00:35:39Z-
dc.date.issued2024-07-01-
dc.identifier.citationCancers, 2024, v. 16, n. 14-
dc.identifier.issn2072-6694-
dc.identifier.urihttp://hdl.handle.net/10722/369641-
dc.description.abstractThe aim of this study was to conduct a comprehensive review of the predictive significance of PNI in HNSCC survival outcomes. A systematic search was conducted across multiple databases, and all studies published in the last decade were screened (Research Registry ID: reviewregistry1853). The included studies were assessed using the Quality in Prognosis Studies tool. Survival outcome data were extracted, combined, and presented as hazard ratios (HR) with a 95% confidence interval (CI). Totally, 74 studies encompassing 27,559 patients were analyzed and revealed a cumulative occurrent rate of 30% for PNI in HNSCC. PNI+ HNSCC patients had a worse overall survival (HR: 1.91, 95% CI: 1.71–2.13), disease-specific survival (HR: 1.79, 95% CI: 1.55–2.07), disease-free survival (HR: 1.82, 95% CI: 1.69–1.96), local recurrence (HR: 2.54, 95% CI: 1.93–3.33), locoregional recurrence (HR: 2.27, 95% CI: 1.82–2.82), locoregional relapse free survival (HR: 1.77, 95% CI: 1.28–2.45), distant metastasis (HR: 1.82, 95% CI: 1.34–2.48), and distant metastasis-free survival (HR: 2.97, 95% CI: 1.82–4.85) compared to those PNI– patients. The available evidence unequivocally establishes PNI as a critical prognostic factor for worse survival in HNSCC patients.-
dc.languageeng-
dc.publisherMDPI-
dc.relation.ispartofCancers-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjecthead and neck squamous cell carcinoma-
dc.subjectperineural invasion-
dc.subjectprognosis-
dc.subjectsurvival-
dc.titleThe Prognostic Role of Perineural Invasion for Survival in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis-
dc.typeArticle-
dc.identifier.doi10.3390/cancers16142514-
dc.identifier.scopuseid_2-s2.0-85199658163-
dc.identifier.volume16-
dc.identifier.issue14-
dc.identifier.eissn2072-6694-
dc.identifier.issnl2072-6694-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats